André Furco
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 3
- Antifungal resistance and susceptibility 1
- Surgery 2
- Gastrointestinal disorders and treatments 1
- Co-authors
- Jean‐Michel Molina (4 shared papers)Christophe Legendre (1 shared paper)A. Bourgarit (1 shared paper)D. Séréni (1 shared paper)Frank Martinez (1 shared paper)Matthieu Lafaurie (1 shared paper)Alexandre Karras (1 shared paper)D Droz (1 shared paper)
In The Last Decade
André Furco
11 papers receiving 422 citations
Peers
Comparison fields: 5 of 47
- Virology 79
- Infectious Diseases 246
- Emergency Medicine 76
- Hepatology 39
- Parasitology 33
Countries citing papers authored by André Furco
This map shows the geographic impact of André Furco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Furco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Furco more than expected).
Fields of papers citing papers by André Furco
This network shows the impact of papers produced by André Furco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Furco. The network helps show where André Furco may publish in the future.
Co-authors
The 25 scholars most cited alongside André Furco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 289 | |
| 2 | 2005 | 77 | |
| 3 | 2007 | 21 | |
| 4 | 2008 | 15 | |
| 5 | [Pulmonary mucormycosis: benefit of aerosol amphotericin B?]. | 2001 | 12 |
| 6 | [Metastatic cancer of the prostate in a 40-year-old HIV-infected male patient]. | 2003 | 11 |
| 7 | 2005 | 9 | |
| 8 | 2006 | 8 | |
| 9 | 2023 | 2 | |
| 10 | [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment]. | 2005 | 2 |
| 11 | 2005 | 1 |
About André Furco
André Furco is a scholar working on Infectious Diseases, Surgery, Virology, Epidemiology and Pharmacology, having authored 11 papers that have together received 447 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (3 papers), Multiple and Secondary Primary Cancers (1 paper), Toxoplasma gondii Research Studies (1 paper), Zoonotic diseases and public health (1 paper), Virology and Viral Diseases (1 paper), Metabolism and Genetic Disorders (1 paper), Antifungal resistance and susceptibility (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Virology (79 citations), Infectious Diseases (246 citations), Emergency Medicine (76 citations), Hepatology (39 citations) and Parasitology (33 citations). André Furco has collaborated with scholars based in France, Singapore and Indonesia. Frequent co-authors include Jean‐Michel Molina, Christophe Legendre, A. Bourgarit, D. Séréni, Frank Martinez, Matthieu Lafaurie, Alexandre Karras, D Droz, Laurence Gérard and C Maylin. Their work appears in journals such as Antiviral Therapy, Clinical Infectious Diseases, AIDS, Diseases of the Colon & Rectum and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.